These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3088582)

  • 1. Liver transplantation in the ciclosporin era.
    Starzl TE; Iwatsuki S; Shaw BW; Gordon RD; Esquivel C
    Prog Allergy; 1986; 38():366-94. PubMed ID: 3088582
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of liver transplantation.
    Starzl TE; Iwatsuki S; Van Thiel DH; Gartner JC; Zitelli BJ; Malatack JJ; Schade RR; Shaw BW; Hakala TR; Rosenthal JT; Porter KA
    Hepatology; 1982; 2(5):614-36. PubMed ID: 6749635
    [No Abstract]   [Full Text] [Related]  

  • 3. Beneficial effect of topical ice cooling in donor hepatonephrectomy.
    Cho SI; Zalneraitis BP; Bradley JW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2429-30. PubMed ID: 3274532
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression and other nonsurgical factors in the improved results of liver transplantation.
    Starzl TE; Iwatsuki S; Shaw BW; Gordon RD; Esquivel CO
    Semin Liver Dis; 1985 Nov; 5(4):334-43. PubMed ID: 3909427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 6. Coenzyme Q, alpha tocopherol and delayed function in human kidney transplantation.
    Serino F; Citterio F; Lippa S; Oradei A; Agnes S; Nanni G; Pozzetto A; Littarru G; Castagneto M
    Transplant Proc; 1990 Aug; 22(4):1375-8. PubMed ID: 2389334
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of immunological risk factors on the outcome of cadaveric renal transplantation as revealed in transplants with primary graft anuria.
    Madsen M; Fjeldborg O; Rasmussen A; Povlsen JV; Kissmeyer-Nielsen F
    Transplant Proc; 1990 Aug; 22(4):1371-2. PubMed ID: 2389332
    [No Abstract]   [Full Text] [Related]  

  • 8. Ciclosporin and ischemia time in renal transplant.
    Vegeto A; Berardinelli L; Beretta C; Pasciucco A; Montagnino G
    Contrib Nephrol; 1986; 51():137-9. PubMed ID: 3552410
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicenter impact of ciclosporin on cadaver kidney graft survival.
    Opelz G
    Prog Allergy; 1986; 38():329-45. PubMed ID: 3523494
    [No Abstract]   [Full Text] [Related]  

  • 10. Two years of ciclosporin in the North Italy Transplant Program.
    Scalamogna M; Pizzi C; Mercuriali F; Poli F; Lecchi L; Rossini G; Sirchia G
    Contrib Nephrol; 1986; 51():39-44. PubMed ID: 3552418
    [No Abstract]   [Full Text] [Related]  

  • 11. The spectrum of ciclosporin nephrotoxicity.
    Puschett JB; Greenberg A; Holley J; McCauley J
    Am J Nephrol; 1990; 10(4):296-309. PubMed ID: 2240057
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney preservation and early function in the cyclosporine era: an overview.
    Williams GM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):38-43. PubMed ID: 3515692
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in liver transplantation.
    Gordon RD; Iwatsuki S; Esquivel CO; Makowka L; Todo S; Tzakis AG; Marsh JW; Starzl TE
    Adv Surg; 1988; 21():49-64. PubMed ID: 3120501
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver transplantation--1978.
    Starzl TE; Koep LJ; Halgrimson CG; Hood J; Schröter GP; Porter KA; Weil R
    Transplant Proc; 1979 Mar; 11(1):240-6. PubMed ID: 109961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and kidney transplantation in children receiving cyclosporin A and steroids.
    Starzl TE; Iwatsuki S; Malatack JJ; Zitelli BJ; Gartner JC; Hakala TR; Rosenthal JT; Shaw BW
    J Pediatr; 1982 May; 100(5):681-6. PubMed ID: 6802949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
    Alexander JW; Vaughn WK; Pfaff WW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants.
    Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):641-6. PubMed ID: 3547834
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with cyclosporin/prednisolone therapy in kidney transplantation, with special reference to nephrotoxicity, ATN and kidney preservation.
    Pichlmayr R; Wonigeit K; Klempnauer J; Ringe B; Bunzendahl H; Kreller H; Heigel B; Siegismund S
    Neth J Med; 1985; 28(6):268-71. PubMed ID: 3892330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.